Takeda Pharmaceutical
341 hedge funds and large institutions have $1.31B invested in Takeda Pharmaceutical in 2025 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 98 increasing their positions, 125 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.05% less ownership
Funds ownership: 2.68% → 2.63% (-0.05%)
22% less repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 125
Holders
341
Holding in Top 10
–
Calls
$32.6M
Puts
$2.54M
Top Buyers
| 1 | +$57.4M | |
| 2 | +$40.8M | |
| 3 | +$16.3M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$12.6M |
| 5 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$6.6M |
Top Sellers
| 1 | -$31.2M | |
| 2 | -$25.3M | |
| 3 | -$23.8M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$22.6M |
| 5 |
Morgan Stanley
New York
|
-$18.8M |
